Magnitude of arterial carbon dioxide change at initiation of extracorporeal membrane oxygenation support is associated with survival

Melania M. Bembea, Ramon Lee, Desiree Masten, Kathleen K. Kibler, Christoph U. Lehmann, Kenneth M. Brady, R. Blaine Easley

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Many patient factors have been associated with mortality from extracorporeal membrane oxygenation (ECMO) therapy. Pre-ECMO patient pH and arterial carbon dioxide (paCO2) have been associated with poor outcome and can be significantly altered by ECMO initiation. We hypothesized that the magnitude of change in paCO2 and pH with ECMO initiation could be associated with survival. We designed a retrospective observational study from a single tertiary care center and included all pediatric patients (age younger than 18 years) undergoing ECMO between 2002 and 2010. Electronic records were queried for demographics and clinical characteristics, including the arterial blood gas (ABG) pre- and post-ECMO initiation. Bivariate analysis compared ECMO course characteristics by outcome (survivor vs. nonsurvivor). Multivariable logistic regression was performed on factors associated with the outcome in the bivariate analysis at the significance level of p <.1. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were reported. We identified 201 patients with a median age of 10 days (range, 1 day to 16 years). Indications for ECMO were: respiratory failure (51%), cardiac failure (23%), extracorporeal cardiopulmonary resuscitation (21%), and sepsis (5%). Mortality, defined by death before discharge, was 37% (74 of 201). ABG data pre- and post-ECMO initiations were available in 84% (169 of 201). Age, pH, paCO2, indication, and intracranial hemorrhage were significantly associated with mortality (p <.05). After adjusting for potential confounders (age, use of epinephrine, volume of fluid administered, year of ECMO, ECMO indication, and duration of ECMO) by multivariable logistic regression, the magnitude of paCO2 change (≥25 mmHg) was associated with mortality (adjusted OR, 2.21; 95% CI, 1.06-4.63; p =.036). The decrease in paCO2 with ECMO initiation was associated with mortality. Although this change in paCO2 is multifactorial, it represents a modifiable element of clinical management involving pre-ECMO ventilation, ECMO circuit priming, CO2 administration/removal, and may represent a future therapeutic target that could improve survival in pediatric ECMO.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalJournal of Extra-Corporeal Technology
Volume45
Issue number1
StatePublished - Aug 20 2013
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Carbon Dioxide
Survival
Mortality
Gases
Logistic Models
Odds Ratio
Confidence Intervals
Pediatrics
Intracranial Hemorrhages
Cardiopulmonary Resuscitation

Keywords

  • ECLS
  • ECMO
  • Extracorporeal life support
  • Extracorporeal membrane oxygenation
  • Outcome
  • Pediatric

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Cardiology and Cardiovascular Medicine
  • Health Professions (miscellaneous)

Cite this

Magnitude of arterial carbon dioxide change at initiation of extracorporeal membrane oxygenation support is associated with survival. / Bembea, Melania M.; Lee, Ramon; Masten, Desiree; Kibler, Kathleen K.; Lehmann, Christoph U.; Brady, Kenneth M.; Easley, R. Blaine.

In: Journal of Extra-Corporeal Technology, Vol. 45, No. 1, 20.08.2013, p. 26-32.

Research output: Contribution to journalArticle

Bembea, Melania M. ; Lee, Ramon ; Masten, Desiree ; Kibler, Kathleen K. ; Lehmann, Christoph U. ; Brady, Kenneth M. ; Easley, R. Blaine. / Magnitude of arterial carbon dioxide change at initiation of extracorporeal membrane oxygenation support is associated with survival. In: Journal of Extra-Corporeal Technology. 2013 ; Vol. 45, No. 1. pp. 26-32.
@article{7349a40685924694849b8f091209afd1,
title = "Magnitude of arterial carbon dioxide change at initiation of extracorporeal membrane oxygenation support is associated with survival",
abstract = "Many patient factors have been associated with mortality from extracorporeal membrane oxygenation (ECMO) therapy. Pre-ECMO patient pH and arterial carbon dioxide (paCO2) have been associated with poor outcome and can be significantly altered by ECMO initiation. We hypothesized that the magnitude of change in paCO2 and pH with ECMO initiation could be associated with survival. We designed a retrospective observational study from a single tertiary care center and included all pediatric patients (age younger than 18 years) undergoing ECMO between 2002 and 2010. Electronic records were queried for demographics and clinical characteristics, including the arterial blood gas (ABG) pre- and post-ECMO initiation. Bivariate analysis compared ECMO course characteristics by outcome (survivor vs. nonsurvivor). Multivariable logistic regression was performed on factors associated with the outcome in the bivariate analysis at the significance level of p <.1. Odds ratios (ORs) and 95{\%} confidence intervals (95{\%} CIs) were reported. We identified 201 patients with a median age of 10 days (range, 1 day to 16 years). Indications for ECMO were: respiratory failure (51{\%}), cardiac failure (23{\%}), extracorporeal cardiopulmonary resuscitation (21{\%}), and sepsis (5{\%}). Mortality, defined by death before discharge, was 37{\%} (74 of 201). ABG data pre- and post-ECMO initiations were available in 84{\%} (169 of 201). Age, pH, paCO2, indication, and intracranial hemorrhage were significantly associated with mortality (p <.05). After adjusting for potential confounders (age, use of epinephrine, volume of fluid administered, year of ECMO, ECMO indication, and duration of ECMO) by multivariable logistic regression, the magnitude of paCO2 change (≥25 mmHg) was associated with mortality (adjusted OR, 2.21; 95{\%} CI, 1.06-4.63; p =.036). The decrease in paCO2 with ECMO initiation was associated with mortality. Although this change in paCO2 is multifactorial, it represents a modifiable element of clinical management involving pre-ECMO ventilation, ECMO circuit priming, CO2 administration/removal, and may represent a future therapeutic target that could improve survival in pediatric ECMO.",
keywords = "ECLS, ECMO, Extracorporeal life support, Extracorporeal membrane oxygenation, Outcome, Pediatric",
author = "Bembea, {Melania M.} and Ramon Lee and Desiree Masten and Kibler, {Kathleen K.} and Lehmann, {Christoph U.} and Brady, {Kenneth M.} and Easley, {R. Blaine}",
year = "2013",
month = "8",
day = "20",
language = "English (US)",
volume = "45",
pages = "26--32",
journal = "Journal of Extra-Corporeal Technology",
issn = "0022-1058",
publisher = "American Society of Extra-Corporeal Technology",
number = "1",

}

TY - JOUR

T1 - Magnitude of arterial carbon dioxide change at initiation of extracorporeal membrane oxygenation support is associated with survival

AU - Bembea, Melania M.

AU - Lee, Ramon

AU - Masten, Desiree

AU - Kibler, Kathleen K.

AU - Lehmann, Christoph U.

AU - Brady, Kenneth M.

AU - Easley, R. Blaine

PY - 2013/8/20

Y1 - 2013/8/20

N2 - Many patient factors have been associated with mortality from extracorporeal membrane oxygenation (ECMO) therapy. Pre-ECMO patient pH and arterial carbon dioxide (paCO2) have been associated with poor outcome and can be significantly altered by ECMO initiation. We hypothesized that the magnitude of change in paCO2 and pH with ECMO initiation could be associated with survival. We designed a retrospective observational study from a single tertiary care center and included all pediatric patients (age younger than 18 years) undergoing ECMO between 2002 and 2010. Electronic records were queried for demographics and clinical characteristics, including the arterial blood gas (ABG) pre- and post-ECMO initiation. Bivariate analysis compared ECMO course characteristics by outcome (survivor vs. nonsurvivor). Multivariable logistic regression was performed on factors associated with the outcome in the bivariate analysis at the significance level of p <.1. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were reported. We identified 201 patients with a median age of 10 days (range, 1 day to 16 years). Indications for ECMO were: respiratory failure (51%), cardiac failure (23%), extracorporeal cardiopulmonary resuscitation (21%), and sepsis (5%). Mortality, defined by death before discharge, was 37% (74 of 201). ABG data pre- and post-ECMO initiations were available in 84% (169 of 201). Age, pH, paCO2, indication, and intracranial hemorrhage were significantly associated with mortality (p <.05). After adjusting for potential confounders (age, use of epinephrine, volume of fluid administered, year of ECMO, ECMO indication, and duration of ECMO) by multivariable logistic regression, the magnitude of paCO2 change (≥25 mmHg) was associated with mortality (adjusted OR, 2.21; 95% CI, 1.06-4.63; p =.036). The decrease in paCO2 with ECMO initiation was associated with mortality. Although this change in paCO2 is multifactorial, it represents a modifiable element of clinical management involving pre-ECMO ventilation, ECMO circuit priming, CO2 administration/removal, and may represent a future therapeutic target that could improve survival in pediatric ECMO.

AB - Many patient factors have been associated with mortality from extracorporeal membrane oxygenation (ECMO) therapy. Pre-ECMO patient pH and arterial carbon dioxide (paCO2) have been associated with poor outcome and can be significantly altered by ECMO initiation. We hypothesized that the magnitude of change in paCO2 and pH with ECMO initiation could be associated with survival. We designed a retrospective observational study from a single tertiary care center and included all pediatric patients (age younger than 18 years) undergoing ECMO between 2002 and 2010. Electronic records were queried for demographics and clinical characteristics, including the arterial blood gas (ABG) pre- and post-ECMO initiation. Bivariate analysis compared ECMO course characteristics by outcome (survivor vs. nonsurvivor). Multivariable logistic regression was performed on factors associated with the outcome in the bivariate analysis at the significance level of p <.1. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were reported. We identified 201 patients with a median age of 10 days (range, 1 day to 16 years). Indications for ECMO were: respiratory failure (51%), cardiac failure (23%), extracorporeal cardiopulmonary resuscitation (21%), and sepsis (5%). Mortality, defined by death before discharge, was 37% (74 of 201). ABG data pre- and post-ECMO initiations were available in 84% (169 of 201). Age, pH, paCO2, indication, and intracranial hemorrhage were significantly associated with mortality (p <.05). After adjusting for potential confounders (age, use of epinephrine, volume of fluid administered, year of ECMO, ECMO indication, and duration of ECMO) by multivariable logistic regression, the magnitude of paCO2 change (≥25 mmHg) was associated with mortality (adjusted OR, 2.21; 95% CI, 1.06-4.63; p =.036). The decrease in paCO2 with ECMO initiation was associated with mortality. Although this change in paCO2 is multifactorial, it represents a modifiable element of clinical management involving pre-ECMO ventilation, ECMO circuit priming, CO2 administration/removal, and may represent a future therapeutic target that could improve survival in pediatric ECMO.

KW - ECLS

KW - ECMO

KW - Extracorporeal life support

KW - Extracorporeal membrane oxygenation

KW - Outcome

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=84879285549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879285549&partnerID=8YFLogxK

M3 - Article

C2 - 23691781

AN - SCOPUS:84879285549

VL - 45

SP - 26

EP - 32

JO - Journal of Extra-Corporeal Technology

JF - Journal of Extra-Corporeal Technology

SN - 0022-1058

IS - 1

ER -